SQZ Biotechnologies Co Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
SQZ Biotechnologies Co quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2022.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the quarter ending September 30, 2023 was $983K, a 58.6% decline year-over-year.
  • SQZ Biotechnologies Co Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2023 was $4.6M, a 48.5% decline year-over-year.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2022 was $8.4M, a 1.2% decline from 2021.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2021 was $8.51M, a 136% increase from 2020.
  • SQZ Biotechnologies Co annual Share-based Payment Arrangement, Expense for 2020 was $3.6M, a 70.9% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $8.4M -$102K -1.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-22
2021 $8.51M +$4.9M +136% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $3.6M +$1.49M +70.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $2.11M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.